Eli Lilly & Co. vs. Silence Therapeutics Plc American Depository Share
LLY
Eli Lilly & Co.
$1280.34 +4.46%
VS SLNSilence Therapeutics Plc American Depository Share
$13.61 -3.48%
Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| LLY | SLN | |
|---|---|---|
| Market Cap | $1.09 trillion | $845.92 million |
| Revenue (TTM) | $79.67 billion | $615,000 |
| Net Income (TTM) | $26.71 billion | $-59,953,000 |
LLY leads on 3 of 3 size & scale factors.
Valuation
| LLY | SLN | |
|---|---|---|
| P/E Ratio | 42.98 | — |
| Price / Book | 32.25 | 21.99 |
| Price / Sales | 13.71 | 1375.47 |
LLY and SLN split the valuation factors evenly.
Profitability
| LLY | SLN | |
|---|---|---|
| Net Margin | 33.53% | -9748.46% |
| Return on Equity | 78.84% | -155.84% |
LLY leads on 2 of 2 profitability factors.
Dividend
| LLY | SLN | |
|---|---|---|
| Dividend Yield | 0.54% | — |
| Payout Ratio | 23.23 | — |
LLY and SLN split the dividend factors evenly.
Risk & Sentiment
| LLY | SLN | |
|---|---|---|
| Short Interest | 1.29% | 0.00% |
SLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, SLN overview, SLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.